Medium materiality6/10
ProMIS Neurosciences (PMN) PT Raised to $33 at Chardan
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Chardan raises PMN target to $33; current price $23.99.
Target: $33
Posted price: $23.99
Analyst firm: Chardan Capital
Analyst: Keay Nakae
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.